COVID-19 - September 2, 2020
Oncology Venture announces results from pre-clinical studies
Oncology Venture has announced that its PARP inhibitor Stenoparib (formerly known as 2X-121) has shown in vitro anti-viral activity against Coronavirus in pre-clinical studies. The studies were conducted at the Pathogen and Microbiome Institute at Northern Arizona University (NAU), a U.S. infectious disease test center. Based on these findings, Oncology Venture plans to advance the […]
COVID-19 - September 1, 2020
AstraZeneca issues a commitment for COVID-19 vaccine
AstraZeneca is issuing a commitment to the highest safety standards and to broad and equitable access around the world for its COVID-19 vaccine AZD1222, it states. Follow the science and put patients first At the heart of AstraZeneca’s core values is to “follow the science” and adhere to the highest scientific and clinical standards, making […]
COVID-19 - September 1, 2020
AstraZeneca expands its US COVID-19 vaccine trial
Development of AstraZeneca’s COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups. The US trial, called D8110C00001, is funded by the Biomedical Advanced Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) […]
COVID-19 - August 25, 2020
Test for COVID-19 T cells immunity developed in the UK
Biotech company Indoor Biotechnologies, co-founded by a Cardiff University alumnus, has developed a test for coronavirus T cells which can potentially provide longer-term immunity to the virus than antibodies. The company’s trials found some people who had coronavirus but tested negative for antibodies went on to test positive for T cells – meaning more people […]
COVID-19 - August 17, 2020
COVID-19 in the Nordics: Different strategies and common efforts
The Nordic countries have handled the COVID-19 pandemic differently in many aspects and learning from each other would hopefully benefit our preparedness for another pandemic. As previously reported, given the similarity of the Nordic societies, it is interesting to note how differently some of them have reacted to the current COVID-19 crisis. For example there has […]
COVID-19 - August 17, 2020
Medivir and SciLifeLab collaborate on potential SARS CoV-2 inhibitors
Medivir has entered a research collaboration with the Drug Discovery and Development Platform (DDD) at SciLifeLab on potential inhibitors of SARS CoV-2. Through the collaboration, DDD will get access to Medivir’s protease-targeted compound library, states the company in its press release. Data will be released on-line The aim of the collaboration is to find potential […]
